SCIENTIFIC BACKGROUND

DMPK

Category:

Myotonic dystrophies are multisystemic diseases with an autosomal dominant inheritance pattern that represent the most common muscular dystrophies in adults. The prevalence of myotonic dystrophy type 1 (DM1) is estimated at 1:8,000. Onset of symptoms, such as myotonia characterized by delayed relaxation of a tense muscle, is most often observed in early adulthood. In addition, there is muscle weakness and fatigue, as well as dysphagia, an elongated face with poor facial expression, cataracts, diabetes mellitus, and cardiac arrythmias; in men there is early development of a bald forehead and testicular atrophy. The clinical presentation of DM1 is categorized into four partially overlapping phenotypes: asymptomatic, mild, classic, and neonatal. The congenital form is characterized by pronounced muscle hypotonia, often clubfoot formation, and is usually associated with respiratory insufficiency difficulty drinking. Psychomotor development is often delayed. This type occurs predominantly when the disease is passed down from the mother and only in DM1.

 

DM1 is caused by a CTG repeat expansion in the non-translated 3' region of the DMPK gene on chromosome 19 which encodes a protein kinase. DM2 (proximal myotonic myopathy), which is important for differential diagnosis, is caused by expansion of a CCTG repeat in intron 1 of the ZNF9 gene on chromosome 3. The phenomenon of anticipation—meaning a decrease in the age of onset of the disease and/or an increase in the severity of symptoms from one generation to the next—is particularly pronounced in DM1. Healthy individuals have 5-36 CTG repeats in the DMPK gene while DM patients have up to approximately 1,000. Children with the congenital type have more than 1,000 repeats.

 

References

Ashizawa et al. 2018, Neurol Clin Pract 8:507 / Pratte et al. 2015, Am J Med Genet A 167A:708 / Turner et al. 2010, J Neurol Neurosurg Psychiatry 81:358 / Schara et al. 2006, Semin Pediatr Neurol 13:71  / Ranum et al. 2004, Am J Hum Genet 74:793 / Larkin et al. 2001, Brain Res Bull 56:389

GENES

DMPK

ASSOCIATED TESTS

How to order

LATEST ARTICLES

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more

Reproductive health is a fundamental aspect of human well-being, affecting individuals and communities worldwide [1]. It encompasses a wide range of ...

Read more

It seems as though everyone is talking about artificial intelligence, usually referred to as AI, these days! Indeed, not only are AI tools now access...

Read more

Orphan drugs are those developed specifically for the treatment of rare diseases. Within the pharmaceutical industry, the drug development process is...

Read more

A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti...

Read more

Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati...

Read more

Cardiovascular diseases affect the heart and blood vessels and are a leading cause of illness and death. Some are hereditary, and genetic testing can...

Read more

A recent study tracked molecular changes in 108 people over time, revealing that aging involves critical shifts around ages 44 and 60. These changes ...

Read more

In May 2024, the American Society of Clinical Oncology (ASCO) published new guidelines for germline genetic testing in patients with cancer (1). ...

Read more

Genetics as we know and understand it today has been shaped, over decades, by the work of many dedicated scientists around the world, and they all de...

Read more